Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ALUR NASDAQ:GEVO NYSEAMERICAN:KULR NASDAQ:LUCD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$0.71+3.7%$0.78$0.23▼$3.33$10.65M-0.181.63 million shs31,913 shsGEVOGevo$1.86-2.1%$1.99$1.10▼$2.97$462.48M13.28 million shs2.50 million shsKULRKULR Technology Group$4.78-1.6%$2.92$1.94▼$10.56$224.81M22.98 million shs3.35 million shsLUCDLucid Diagnostics$1.03-1.9%$1.12$0.90▼$1.63$213.22M1.1922,765 shs772,293 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies-18.75%-17.72%-12.19%-44.68%-74.41%GEVOGevo+5.56%+11.76%+3.83%+4.40%+61.70%KULRKULR Technology Group+2.97%+25.58%+100.00%+72.95%-48.08%LUCDLucid Diagnostics+0.96%+5.00%+0.96%-27.08%-30.92%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALURAllurion Technologies$0.71+3.7%$0.78$0.23▼$3.33$10.65M-0.181.63 million shs31,913 shsGEVOGevo$1.86-2.1%$1.99$1.10▼$2.97$462.48M13.28 million shs2.50 million shsKULRKULR Technology Group$4.78-1.6%$2.92$1.94▼$10.56$224.81M22.98 million shs3.35 million shsLUCDLucid Diagnostics$1.03-1.9%$1.12$0.90▼$1.63$213.22M1.1922,765 shs772,293 shsBeginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALURAllurion Technologies-18.75%-17.72%-12.19%-44.68%-74.41%GEVOGevo+5.56%+11.76%+3.83%+4.40%+61.70%KULRKULR Technology Group+2.97%+25.58%+100.00%+72.95%-48.08%LUCDLucid Diagnostics+0.96%+5.00%+0.96%-27.08%-30.92%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALURAllurion Technologies 2.00Hold$3.00322.54% UpsideGEVOGevo 2.00Hold$6.50249.46% UpsideKULRKULR Technology Group 0.00N/AN/AN/ALUCDLucid Diagnostics 2.60Moderate Buy$4.13300.49% UpsideCurrent Analyst Ratings BreakdownLatest ALUR, LUCD, KULR, and GEVO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/26/2026GEVOGevo HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/22/2026GEVOGevo UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$2.25 ➝ $2.005/15/2026LUCDLucid Diagnostics Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$3.00 ➝ $2.005/15/2026LUCDLucid Diagnostics BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$2.505/8/2026GEVOGevo Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/6/2026LUCDLucid Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026GEVOGevo Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/16/2026GEVOGevo Northland SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOutperform$3.75 ➝ $3.504/9/2026LUCDLucid Diagnostics Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$8.25 ➝ $9.003/30/2026LUCDLucid Diagnostics BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$2.503/26/2026LUCDLucid Diagnostics Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$3.00(Data available from 5/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALURAllurion Technologies$17.21M0.62N/AN/A($30.08) per share-0.02GEVOGevo$160.58M2.82N/AN/A$1.84 per share1.01KULRKULR Technology Group$16.17M13.67N/AN/A$2.04 per share2.34LUCDLucid Diagnostics$4.71M44.41N/AN/A($0.03) per share-34.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALURAllurion Technologies-$7.20M-$10.56N/AN/AN/A-199.96%N/A-77.13%8/12/2026 (Estimated)GEVOGevo-$33.84M-$0.13N/AN/AN/A-19.38%-5.06%-3.41%8/10/2026 (Estimated)KULRKULR Technology Group-$61.90M-$0.12N/AN/AN/A-383.52%-45.70%-43.00%8/13/2026 (Estimated)LUCDLucid Diagnostics-$58.01M-$0.47N/AN/AN/A-876.72%N/A-116.26%8/12/2026 (Estimated)Latest ALUR, LUCD, KULR, and GEVO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026KULRKULR Technology Group-$0.08-$0.61-$0.53-$0.61$8.50 million$4.85 million5/14/2026Q1 2026LUCDLucid Diagnostics-$0.05-$0.07-$0.02-$0.17$1.38 million$1.26 million5/7/2026Q1 2026GEVOGevo-$0.02-$0.05-$0.03-$0.09$44.90 million$42.95 million3/25/2026Q4 2025LUCDLucid Diagnostics-$0.07-$0.10-$0.03-$0.12$1.39 million$1.50 million3/5/2026Q4 2025GEVOGevo-$0.03-$0.02+$0.01-$0.02$43.52 million$45.35 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthALURAllurion TechnologiesN/AN/AN/AN/AN/AGEVOGevoN/AN/AN/AN/AN/AKULRKULR Technology GroupN/AN/AN/AN/AN/ALUCDLucid DiagnosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALURAllurion TechnologiesN/A1.260.94GEVOGevo0.374.313.51KULRKULR Technology GroupN/A1.691.55LUCDLucid DiagnosticsN/A1.071.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALURAllurion Technologies21.39%GEVOGevo35.17%KULRKULR Technology Group21.23%LUCDLucid Diagnostics74.01%Insider OwnershipCompanyInsider OwnershipALURAllurion Technologies8.10%GEVOGevo7.09%KULRKULR Technology Group6.57%LUCDLucid Diagnostics6.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALURAllurion Technologies50114.99 million11.28 millionNo DataGEVOGevo100243.41 million226.15 millionOptionableKULRKULR Technology Group6046.26 million43.22 millionNot OptionableLUCDLucid Diagnostics70203.07 million189.26 millionNo DataALUR, LUCD, KULR, and GEVO HeadlinesRecent News About These CompaniesDennis Matheis Buys 245,000 Shares of Lucid Diagnostics (NASDAQ:LUCD) StockMay 22, 2026 | insidertrades.comCanaccord Genuity Sticks to Its Buy Rating for Lucid Diagnostics (LUCD)May 16, 2026 | theglobeandmail.comLucid Diagnostics Inc (LUCD) Q1 2026 Earnings Call Highlights: Exceeding Test Targets and ...May 15, 2026 | finance.yahoo.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2026 Earnings Call TranscriptMay 15, 2026 | insidermonkey.comPAVmed Provides Business Update and Reports First Quarter 2026 Financial ResultsMay 15, 2026 | prnewswire.comLucid Diagnostics Earnings Call Balances Progress, PressureMay 14, 2026 | tipranks.comLucid Diagnostics Inc. (LUCD) Q1 2026 Earnings Call TranscriptMay 14, 2026 | seekingalpha.comLucid Diagnostics Q1 Earnings Call HighlightsMay 14, 2026 | marketbeat.comLucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue EstimatesMay 14, 2026 | zacks.comLucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial ResultsMay 14, 2026 | prnewswire.comLucid Diagnostics Inc (LUCD) Q1 2026 Earnings Report Preview: What To Look ForMay 13, 2026 | finance.yahoo.comLucid Diagnostics (NASDAQ:LUCD) Stock Rating Lowered by Wall Street ZenMay 9, 2026 | marketbeat.comLucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseMay 8, 2026 | zacks.comLucid Diagnostics (LUCD) to Release Earnings on ThursdayMay 7, 2026 | marketbeat.comPAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026May 1, 2026 | prnewswire.comLucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026April 30, 2026 | prnewswire.comLucid Diagnostics closes $18M offeringApril 24, 2026 | massdevice.comLucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common StockApril 24, 2026 | prnewswire.comLucid Diagnostics Prices $18 Million Public Equity OfferingApril 23, 2026 | tipranks.comLucid Diagnostics Announces $18 Million Underwritten Offering of Common StockApril 23, 2026 | prnewswire.comLucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare ConferenceApril 9, 2026 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeALUR, LUCD, KULR, and GEVO Company DescriptionsAllurion Technologies NYSE:ALUR$0.71 +0.03 (+3.71%) As of 02:27 PM EasternAllurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Gevo NASDAQ:GEVO$1.86 -0.04 (-2.11%) Closing price 04:00 PM EasternExtended Trading$1.86 0.00 (-0.22%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Gevo, Inc. operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was incorporated in 2005 and is headquartered in Englewood, Colorado.KULR Technology Group NYSEAMERICAN:KULR$4.78 -0.08 (-1.65%) Closing price 04:10 PM EasternExtended Trading$4.72 -0.06 (-1.15%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.KULR Technology Group, Inc., through its subsidiary, KULR Technology Corporation, develops and commercializes thermal management technologies for electronics, batteries, and other components applications in the United States. It provides lithium-ion battery thermal runaway shields; automated battery cell screening and test systems; cellchecks; safecases; fiber thermal interface materials; phase change material heat sinks; internal short circuit devices; and CRUX cathodes. The company's technologies are used in electric vehicles, energy storage, battery recycling transportation, cloud computing, and 5G communication devices. It sells its products for applications, such as lithium-ion battery energy storage, electric vehicles, 5G communication, cloud computer infrastructure, consumer, and industrial devices. The company was formerly known as KT High-Tech Marketing Inc. and changed its name to KULR Technology Group, Inc. in August 2018. KULR Technology Group, Inc. was founded in 2013 and is based in San Diego, California.Lucid Diagnostics NASDAQ:LUCD$1.03 -0.02 (-1.90%) Closing price 04:00 PM EasternExtended Trading$1.04 +0.01 (+1.46%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys Dollar Tree Keeps Winning After Family Dollar Divorce Salesforce Stock Finds Support as AI Momentum Builds Marvell’s Pullback May Be the Setup Bulls Were Waiting For Snowflake and the Snowballing Impact of its AI Flywheel China Deal Ignites Boeing's Financial Afterburners IREN Is Flipping the Switch from Bitcoin to AI Flight Path to Profits: American Airlines Bets on SpaceX Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
